REFERENCES
1. Lussier B, Wilson AA. Alpha-1 antitrypsin: The protein. Alpha-1 Antitrypsin, Springer; 2016, 17-30.
2. Teckman JH, Lindblad D. Alpha-1-antitrypsin deficiency: diagnosis, pathophysiology, and management. Curr Gastroenterol Rep . 2006;8:14-20.
3. Perlmutter DH, Daniels JD, Auerbach HS, De Schryver-Kecskemeti K, Winter HS, Alpers DH. The alpha 1-antitrypsin gene is expressed in a human intestinal epithelial cell line. J Biol Chem.1989;264:9485-9490.
4. Janciauskiene S, Wrenger S, Immenschuh S, Olejnicka B, Greulich T, Welte T, et al. The Multifaceted effects of alpha-1-antitrypsin on neutrophil functions. Front Pharmacol. 2018;9:341.
5. Duranton J, Bieth JG. Inhibition of proteinase 3 by [alpha]1-antitrypsin in vitro predicts very fast inhibition in vivo.Am J Respir Cell Mol Biol. 2003;29:57-61.
6. Blanco I, Bueno P, Diego I, Pérez-Holanda S, Casas-Maldonado F, Esquinas C, et al. Alpha-1 antitrypsin Pi*Z gene frequency and Pi*ZZ genotype numbers worldwide: an update. Int J Chron Obstruct Pulmon Dis. 2017;12:561-569.
7. Blanco I, Bueno P, Diego I, Pérez-Holanda S, Lara B, Casas-Maldonado F, et al. Alpha-1 antitrypsin Pi*SZ genotype: estimated prevalence and number of SZ subjects worldwide. Int J Chron Obstruct Pulmon Dis.2017;12:1683-1694.
8. Lomas DA, Evans DL, Finch JT, Carrell RW. The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature.1992;357:605-607.
9. de Serres F, Blanco I. Role of alpha-1 antitrypsin in human health and disease. J Intern Med. 2014;276:311-335
10. de Serres FJ, Blanco I. Prevalence of α1-antitrypsin deficiency alleles PI*S and PI*Z worldwide and effective screening for each of the five phenotypic classes PI*MS, PI*MZ, PI*SS, PI*SZ, and PI*ZZ: a comprehensive review. Ther Adv Respir Dis. 2012;6:277-295.
11. Yuen KS, Ye ZW, Fung SY, Chan CP, Jin DY. SARS-CoV-2 and COVID-19: The most important research questions. Cell Biosci. 2020;10:40.
12. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239-1242.
13. COVID-19 Coronavirus Pandemic 2020. https://www.worldometers.info/coronavirus/. Accessed March. 30, 2021.
14. Felisbino MB, Fernandes FLA, Nucci MCNM, Pinto RMC, Pizzichini E, Cukier A. The patient profile of individuals with Alpha-1 antitrypsine gene mutations at a referral center in Brazil. J Bras Pneumol.2018;44(5):383-389.
15. Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency.Lancet. 2005;365:2225-2236.
16. Kommoss FKF, Schwab C, Tavernar L, Schreck J, Wagner WL, Merle U, et al. The Pathology of Severe COVID-19-Related Lung Damage. Dtsch Arztebl Int. 2020;117(29-30):500-506.
17. Kim DH, Choe YJ, Jeong JY. Understanding and Interpretation of Case Fatality Rate of Coronavirus Disease 2019. J Korean Med Sci.2020;35:e137.
18. Luisetti M, Massi G, Massobrio M, Guarraci P, Menchicchi FM, Beccaria M, et al. A national program for detection of alpha 1-antitrypsin deficiency in Italy. Respir Med.1999;93(3):169-172.
19. de Serres FJ, Luisetti M, Ferrarotti I, Blanco I, Fernández-Bustillo E. Alpha-1 antitrypsin deficiency in Italy: regional differences of the PIS and PIZ deficiency alleles. Monaldi Arch Chest Dis.2005;63(3):133-141.
20. Goumenou M, Sarigiannis D, Tsatsakis A, Anesti O, Docea AO, Petrakis D, et al. COVID‑19 in Northern Italy: An integrative overview of factors possibly influencing the sharp increase of the outbreak (Review).Mol Med Rep. 2020;22(1):20-32.
21. Vianello A, Braccioni F. Geographical Overlap Between Alpha-1 Antitrypsin Deficiency and COVID-19 Infection in Italy: Casual or Causal? Arch Bronconeumol. 2020;56(9):609-610.
22. de Serres FJ, Blanco I, Fernández-Bustillo E. Ethnic differences in alpha-1 antitrypsin deficiency in the United States of America.Ther Adv Respir Dis. 2010;4:63-70.
23. Luisetti M, Seersholm N. Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency. Thorax.2004;59(2):164-169.
24. Shapira G, Shomron N, Gurwitz D. Ethnic differences in alpha-1 antitrypsin deficiency allele frequencies may partially explain national differences in COVID-19 fatality rates. FASEB J.2020;34(11):14160-14165.
Table 1: Distribution of COVID-19 cases and deaths and the number of individuals with alpha-1-antitrypsin PI*SZ and PI*ZZ genotypes in European countries.